Talty Ronan, Olino Kelly
Department of Pathology, Yale University, New Haven, CT 06520, USA.
Department of Surgery, Yale University, New Haven, CT 06520, USA.
Cancers (Basel). 2021 Feb 21;13(4):904. doi: 10.3390/cancers13040904.
Cancer cells possess specific metabolic requirements for their survival, proliferation, and progression. Within a shared microenvironment, immune cells depend on competing metabolic pathways for their development and effector function. As a result, local acidification, hypoxia, and nutrient depletion in the tumor microenvironment can alter the antitumor immune response and even promote resistance to immunotherapies such as immune checkpoint blockade and adoptive cell transfer. Although T cells are the primary effectors of the antitumor response, growing evidence demonstrates that innate immune cells are critical to successful tumor clearance. This review aims to summarize current research related to the innate immune system, metabolism, and cancer. We first discuss the specific metabolic requirements of innate immune cells for immune activation and suppression and conclude by highlighting ongoing clinical applications of these findings.
癌细胞的存活、增殖和进展需要特定的代谢条件。在共享的微环境中,免疫细胞依靠相互竞争的代谢途径来实现其发育和效应功能。因此,肿瘤微环境中的局部酸化、缺氧和营养耗竭会改变抗肿瘤免疫反应,甚至促进对免疫疗法(如免疫检查点阻断和过继性细胞转移)的抗性。尽管T细胞是抗肿瘤反应的主要效应细胞,但越来越多的证据表明,先天免疫细胞对于成功清除肿瘤至关重要。本综述旨在总结当前与先天免疫系统、代谢和癌症相关的研究。我们首先讨论先天免疫细胞免疫激活和抑制的特定代谢需求,最后强调这些发现正在进行的临床应用。